Reducing Blood Pressure in Mid-life Adult Binge Drinkers

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-64
SponsorThe University of Texas at Arlington

About this trial

This study has two phases:

Phase 1 is to examine blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers vs. alcohol abstainers/moderate drinkers.

Phase 2 is to examine the effect of 8-week aerobic exercise training on blood pressure, microvascular function, and sympathetic nerve activity in mid-life adult binge drinkers

Eligibility criteria

Qualifiers

Men and women (50-64 years of age) who do not drink alcohol, who drink at moderate levels, or who binge drink

Female subjects will be postmenopausal (i.e., cessation of menses for ≥1 yr).

Subjects who can speak and understand English.

Disqualifiers

a history of diabetes, cardiovascular disease, liver, or renal disease

current or history of smoking and illicit drug use

blood pressure ≥160/100 mm Hg

other known traditional cardiovascular disease risks: obesity (BMI≥35 kg/m2), or hyperlipidemia (total cholesterol>230 mg/dl and/or LDL cholesterol>160 mg/dl)

Trial design

Treatments tested in this trial

  • Exercise Training
  • Alcohol Abstinence Intervention

Treatment groups

55 Participants
are divided into 3 treatment groups

Sponsors and collaborators

The University of Texas at Arlington

Lead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Collaborator